Abstract:Objective To assess the endogenous regulation of platelet derived growth factor (PDGF) in the foot wound healing response induced by negative pressure wound therapy (NPWT) in human diabetic patients in vivo. Methods From January 2010 to December 2014, 40 patients with diabetic foot wounds fitting the inclusion criteria were found and enrolled in the clinical trial. The subjects were randomly assigned for NPWT group or control group with simple random sampling method. Twenty patients were treated with NPWT, while the same number of patients in the control group received conventional gauze therapy. Granulated tissue biopsies were collected before(0 day) and after(12 days) treatment in both groups. All biopsies were subdivided into two parts. One part was preserved in 4% paraformaldehyde for hematoxylin eosin staining and immunocytochemical staining of PDGF, the other part was stored at -80℃ for Western blot analysis of PDGF expression. Experimental data were analyzed using SPSS 13.0 software and differences of absorbance value and protein expression of PDGF between the two groups were analyzed using two-sample t test. Results The HE staining showed that both NPWT group and control group wounds developed characteristic granulated tissue after treatment, which presented intense fibroblasts and neoformation of vessels. However, NPWT group wounds developed much more characteristic granulated tissue than control group wounds. The immunohistochemical data revealed that PDGF expression was up-regulated in NPWT group and control group after treatment. The absorbance value of PDGF was higher after treatment than that before treatment in NPWT group, the difference was statistically significant (0.41±0.05 vs 0.29±0.04, t=8.63, P<0.05). Also, the absorbance value of PDGF was higher after treatment than that before treatment in control group, the difference was statistically significant (0.33±0.04 vs 0.28±0.04, t=3.62, P<0.05). However, the change value (difference between before treatment and after treatment) of absorbance value of PDGF was higher in NPWT group than that in control group, the difference was statistically significant (0.13±0.05 vs 0.05±0.03, t=5.89, P<0.05). The Western blot analysis of PDGF was consistent with that of immunohistochemical analysis. The protein levels of PDGF was higher after treatment than that before treatment in NPWT group, the difference was statistically significant (0.24 ±0.04 vs 0.11±0.03, t=11.01, P<0.05). Also, the protein level of PDGF was higher after treatment than that before treatment in control group, the difference was statistically significant (0.17±0.03 vs 0.12±0.03, t=6.06, P<0.05). But, the change value ( difference between before treatment and after treatment) of protein level of PDGF was higher in NPWT group than that in control group, the difference was statistically significant (0.12 ±0.03 vs 0.05 ±0.02, t=9.06, P<0.05). Conclusion NPWT obviously enhances PDGF expression of granulation tissue in diabetic foot wound and subsequently promotes wound healing. Key words: Negative-pressure wound therapy; Diabetic foot; Receptors, platelet derived growth factor

Influence of negative pressure wound therapy on collagen formation in granulation tissue in human diabetic foot wounds

Effects of Negative Pressure Wound Therapy on the Expression of Type Ⅰ Collagen in Granulation Tissue of Different Ischemic Wound of Diabetic Foot

Effect of Negative Pressure Wound Therapy on the Expression of Platelet Derived Growth Factor in Granulation Tissue of Diabetic Foot Wounds

Effects of negative pressure wound therapy on the expression of EDA+FN in granulation tissues of human diabetic foot wounds

Effect of Negative Pressure Wound Therapy on Cellular Fibronectin and Transforming Growth Factor-β1 Expression in Diabetic Foot Wounds.

Impact of Negative Pressure Wound Therapy on Basic Fibroblast Growth Factor in Human Diabetic Foot Wounds

Effect of Negative Pressure Wound Therapy on the Expression of Transforming Growth Factor-Beta1 in Granulation Tissue with Mild and Moderate Ischemia Wound of Diabetic Foot

Effect of Negative Pressure Wound Therapy on EDA+ FN Level in Different Ischemia Granulation Tissues of Diabetic Foot Wounds

Negative Pressure Wound Therapy is Associated with Up-Regulation of Bfgf and ERK1/2 in Human Diabetic Foot Wounds.

Negative pressure wound therapy inhibits inflammation and upregulates activating transcription factor-3 and downregulates nuclear factor-κB in diabetic patients with foot ulcerations.

Proteomics changes after negative pressure wound therapy in diabetic foot ulcers

Negative pressure wound therapy (NPWT) is superior to conventional moist dressings in wound bed preparation for diabetic foot ulcers: A randomized controlled trial

Effect of Compound Xuejie Powder combined with negative pressure wound therapy on diabetic foot ulcers and blood flow in the dorsal foot artery

The effect of negative pressure wound therapy on the outcome of diabetic foot ulcers: A meta‐analysis

Negative-Pressure Wound Therapy Induces Lymphangiogenesis in Murine Diabetic Wound Healing

Combination therapy of negative pressure wound therapy and antibiotic‐loaded bone cement for accelerating diabetic foot ulcer healing: A prospective randomised controlled trial

Downregulation of hsa-miR-203 in peripheral blood and wound margin tissue by negative pressure wound therapy contributes to wound healing of diabetic foot ulcers

Enhancing diabetic foot ulcer healing: Impact of the regulation of the FUS and ILF2 RNA‑binding proteins through negative pressure wound therapy

Consensus on the application of negative pressure wound therapy of diabetic foot wounds

Evaluation of a new low-cost negative pressure wound therapy in the treatment of diabetic foot ulcers

The effectiveness of negative pressure wound therapy compared to the traditional method in the treatment of diabetic foot